Look Towards A New Future

Jan 18, 2013

Research on China’s Coal Tar Industry, 2013-2017

Coal tar products play an extremely important role in the world chemical raw materials. The development of tar chemical is one of the very important topics in many countries. Countries are actively developing coal tar depth processing and new separation technology so as to produce marketable and high value-added new products.

During 2010-2011, China's coal tar annual production capacity is increasing year by year; the average annual growth rate is about 20%. But China's coal tar market is weak in 2012; its total production capacity is about 22 million tons, increasing 4.30% compared with 2011. In terms of regional distribution, affected by the raw materials, coal tar is still mainly distributed in North China and East China.

The operating rate of coal tar enterprises was not high in the first half of 2012, but the overall supply of coke in China still maintain a growth momentum. In the first half of 2012, China's cumulative production of coke was 221,761,000 tons; China's coal tar output was 8,870,440 tons, increasing 6.12% year-on-year.
With the continuous development of China’s economy and the increasing requirements of the environmental protection, the deep processing of coal tar become an urgent issue to solve. Seen from the current development status of coal tar industry, the domestic coal tar industry is at an important period of integration reform. Coal tar industry is developing towards the direction of centralization, fine separation, further processing and the synthesis of new materials. The development of coal tar industry depends on investment and the market. However, with the development of deep processing and the increase of product added value, technology occupies an increasing proportion.

Buy a copy of this report @

Report Details:
Published: January 2013
No. of Pages: 70
Price:Single User License:US$1800             Corporate User License:US$2800  

Contact for further information.

Global and China Carbon Fiber Industry Deep Research Report, 2012-2015

Carbon fiber is a new generation of reinforced fiber, mainly used in the fields of aerospace, wind power, automotive, sports and leisure. Industrial applications like wind power, automotive and pressure vessel account for the largest demand for carbon fiber, which is more than 60%, followed by aerospace, with enhanced application and hence steadily increased demand; the growth of demand from sports and leisure has been relatively slow. The global carbon fiber demand maintained a CAGR of 14.1% in 2008-2012, and hit 54,500 tons in 2012.

In 2010-2012, as the demand for carbon fiber has been recovered, global leading carbon fiber manufacturers have accelerated the capacity expansion of carbon fiber. In 2012, the global carbon fiber capacity reached 114,000 tons, a year-on-year growth of 18.3%.

Buy a copy of this report @

Due to the complex process and high technical content of carbon fiber Buy production, global carbon fiber capacity is mainly concentrated in Japanese and U.S. enterprises. Japan''s Toray, Toho and Mitsubishi Rayon, mainly engaged in the production of PAN-based small-tow (≤24K) carbon fiber, accounted for 2/3 of the global total small-tow carbon fiber capacity in 2012. Toray is the largest carbon fiber manufacturer in the world, with an annual capacity of 18,900 tons in 2012.

U.S. Zoltek and German SGL, mainly engaged in the production of large-tow (>24K) PAN-based carbon fiber, accounted for about 3/4 of the global large-tow carbon fiber capacity in 2012. Japanese Kureha, mainly engaged in the production of pitch-based carbon fiber, is the largest pitch-based carbon fiber producer in the world, with an annual capacity of 1,800 tons in 2012.

Stimulated by incentive policies and the gap between supply and demand, coupled with the gradual progress of industrial technology, China’s carbon fiber industry is ushering in rapid development. China’s carbon fiber capacity maintained a CAGR of 46.2% in 2008-2012, and reached 14,521 tons in 2012. As China’s carbon fiber production technology hasn’t been mature and most production lines are in the initial stage of production, the plant operating rate has been generally low. In 2012, the actual output was only 3,500 tons, and the import dependency rate was about 70%.

In 2012, China''s major producers of carbon fiber include ZhongFuShenYing, Jiangsu Hengshen, Tianhua Excel-Way, Weihai Tuozhan Fiber, HNCC Yongmei, etc. Among which, only ZhongFuShenYing and Jiangsu Hengshen each boast an annual carbon fiber output of about 1,000 tons, and an annual capacity of 3,000 tons at present.

In addition, there are about 38,000 tons of carbon fiber capacities under planning/construction in China. The projects to be put into production in 2013 include 2,000 t/a carbon fiber project of Kingfa, 1,500 t/a carbon fiber project of Sinosteel Jiangcheng Carbon Fiber, and 1,500 t/a carbon fiber project of Sinopec Shanghai Petrochemical.

Global and China Carbon Fiber Industry Report, 2012-2015 of ResearchInChina mainly covers the followings:

--Global carbon fiber industry supply and demand, competition pattern and price;
--China carbon fiber industry supply and demand, import & export and price;
--China carbon fiber industry competition pattern, projects under planning/construction, supply and demand, consumption structure forecasts, etc.;
--Operation, carbon fiber business and development trends of nine carbon fiber production enterprises overseas;
--Operation, carbon fiber business and development forecasts of nine carbon fiber production enterprises as well as the development trends of 20 carbon fiber producers in mainland China.

Report Details:
Published: January 2013
No. of Pages: 101
Price: Single User License:US$2200        Corporate User License:US$3400

Request a Sample of this report @

Animal Vaccine Industry Research Report in China, 2013-2017

Animal vaccine sales amount in China was about CNY 7.11 billion (excluding net imports); the sales amount of swine vaccine and poultry vaccines were CNY 3.51 billion and 3.01 billion respectively, accounting for 49.4% and 42.3% of the total sales amount respectively. The market scale of China's animal vaccine is nearly CNY 10 billion in 2012.

Although there are nearly 60 animal vaccine manufacturers in China, the market share is concentrated in the hands of a few corporations. CAHIC, Qingdao Yebio Bioengineering Co. Ltd., Dahuanong, TECON and Chengdu TECBOND are the representatives of China’s animal vaccine industry. The five enterprises accounted for 37.9% of China’s animal vaccine market in the first half of 2012.

Among the key animal vaccine manufacturers in China, China Animal Husbandry Industry Co., Ltd (CAHIC) obtained the highest business income in the first half of 2012—CNY 964 million, accounting for 14.3% market share. TECON, Dahuanong and Jinyu Group also had more than 5% market share respectively. The sales of these companies mainly came from the national mandatory vaccine procurement policy. The proportion of the national mandatory vaccine procurement accounted for 82.7% of CAHIC’s total income in the first half of 2012.

In recent years, animal mandatory immunization coverage is gradually expanded in China. Restricted by the economic conditions, compulsory vaccination epidemics only cover five kinds of animal disease. While there are about 17 kinds of animal diseases; other diseases also have great hazard. With farming enterprises and farmers enhanced emphasis on the prevention and control of animal diseases, the demand of conventional vaccine at their own expense will be further improved in the future. Swine and poultry are the main species in China’s livestock breeding, newcastle disease vaccine and porcine circovirus vaccine will be the two conventional vaccines with very good market prospects.

Buy a copy of this report @

Report Details:
Published: January 2013
No. of Pages: 85
Price:Single User License:US$2100      Corporate User License:US$3200

Contact for further information.

Jan 16, 2013

Global and China Vitamin C Industry 2013 Deep Research Report

This is a professional and depth research report on Global and China Vitamin C (Food Grade Feed Grade Pharmaceutical Grade) Industry. Firstly the report describes the background knowledge of Vitamin C, including Vitamin C ((Food Grade Feed Grade Pharmaceutical Grade) Concepts Classification production process technical parameters; then statistics Global and China 14 Manufacturers Vitamin C product 2010-2016 Capacity production cost price production value Gross margins and other relevant data, statistics these enterprises Vitamin C products, customers, raw materials, company background information, then summary statistics and analysis the relevant data of these enterprises. and get Global and China Vitamin C 2010-2016 production market share, different Type Vitamin C production market share, Global and China Vitamin C demand supply and shortage, Global and China Vitamin C 2010-2016 production price cost Gross production value gross margins, etc. At the same time, the report analyzed and discussed supply and demand changes in Vitamin C market and business development strategies, conduct a comprehensive analysis on Global and China Vitamin C industry trends. Finally, the report also introduced 10KT/year Vitamin C project Feasibility analysis and related research conclusions. In a word, It was a depth research report on Global and China Vitamin C industry. And thanks to the support and assistance from Vitamin C industry chain related experts and enterprises during Research Team survey and interviews.

Buy a copy of this report @

Report Details:
Published: January 2013
No. of Pages: 111
Price:Single User License:US$2000 Corporate User License:US$4000

Table of Contents

Chapter One Food Grade Vitamin C Industry Overview 1
1.1 Food Grade Vitamin C Definition 1
1.2 Food Grade Vitamin C Product Specifications 1
1.3 Food Grade Vitamin C Price Analysis 2
1.4 Food Grade Vitamin C Manufacturing Process 2
1.5 Food Grade Vitamin C Cost Structure 3
1.6 Food Grade Vitamin C Industry Overview 4

Chapter Two Pharmaceutical Grade Vitamin C Industry Overview 4
2.1 Pharmaceutical Grade Vitamin C Definition 5
2.2 Pharmaceutical Grade Vitamin C Product Specifications 5
2.3 Pharmaceutical Grade Vitamin C Price Analysis 6
2.4 Pharmaceutical Grade Vitamin C Manufacturing Process 6
2.5 Pharmaceutical Grade Vitamin C Cost Structure 7
2.6 Pharmaceutical Grade Vitamin C Industry Overview 8

Chapter Three Feed Grade Vitamin C Industry Overview 8
3.1 Feed Grade Vitamin C Definition 9
3.2 Feed Grade Vitamin C Product Specifications 9
3.3 Feed Grade Vitamin C Price Analysis 10
3.4 Feed Grade Vitamin C Manufacturing Process 10
3.5 Feed Grade Vitamin C Cost Structure 11
3.6 Feed Grade Vitamin C Industry Overview 12

Chapter Four Vitamin C Industry Chain Analysis 12
4.1 Vitamin C Market Analysis 12
4.2 Vitamin C Industry Chain Analysis 13
Chapter Five Vitamin C Production Supply Sales Demand Market Status and Forecast 15
5.1 Global Vitamin C Capacity Production Overview 15
5.2 China Vitamin C Capacity Production Overview 29
5.3 Netherland China United States etc Regions Vitamin C Production and Market Share 43
5.4 Food Grade Pharmaceutical Grade Feed Grade Vitamin C Production and Market Share 44
5.5 Global and China Key Manufacturers Vitamin C Capacity Utilization Rate 47
5.6 China Vitamin C Capacity Production and Its Global Proportion 49
5.7 Global and China Vitamin C Demand Overview 51
5.8 Global and China Vitamin C Supply Demand Shortage 53
5.9 Global and China Vitamin C Cost Price Production Value Gross Margin 55
5.10 China Vitamin C Import Export Consumption 58

Chapter Six Vitamin C Key Manufacturers 60
6.1 DSM (Netherland) 60
6.2 CSPC Pharmaceutical Group 66
6.3 Northeast Pharmaceutical Group 73
6.4 Northchina Pharmaceutical Group 79
6.5 Aland Nutraceutical Group 86
6.6 Shandong Luwei Pharmaceutical 92

Chapter Seven Vitamin C New Project Investment Feasibility Analysis 98
7.1 Vitamin C New Project SWOT Analysis 98
7.2 10KT/Year Vitamin C New Project Investment Feasibility Analysis 99

Chapter Eight Vitamin C Industry Research Conclusions 99

Contact for further information on this report.

Neuromodulation Market Forecasts to 2017

Neuromodulation devices have emerged as one of the fastest growing segments of the medical device market due to high demand for minimally invasive and non–invasive treatment. With advancements in technology, neuromodulation is expected to become a promising therapeutic area and high growth industry in the next decade, as it offers symptomatic relief mainly from chronic pain, incontinence, heart failure, headache, depression, epilepsy, etc. The neuromodulation devices market includes deep brain stimulation, spinal cord stimulation, vagus nerve stimulation, sacral nerve stimulation and others external stimulation devices such as transcranial magnetic stimulation, and transcutaneous electrical nerve stimulation (TENS).

The neuromodulation technique acts directly upon nerves or the target area where the activity of nerves is altered due to biological responses produced by electrical stimulation or drug infusion. These devices include small electrodes that are attached to the brain, the spinal cord, or peripheral nerves. These precisely placed leads are connected by means of an extension cable to a pulse generator to generate electrical stimulation. Neuromodulation can have applications in any area of the body and can treat several diseases like chronic pain, epilepsy, psychiatric disorder, movement disorder, cardiovascular disorder, genitourinary and colorectal disorder, stroke and brain injury, and gastric disorder.

Report Details:
Published: January 2013
No. of Pages: 193
Price:Single User License:US$4650 Corporate User License:US$7150

The main drivers for the neuromodulation market are the rising population of aged people and age-related diseases like Alzheimer’s, epilepsy, spinal cord injury, and Parkinson’s disease. According to the International Neuromodulation Society, about 40 million to 50 million patients worldwide suffer from epilepsy, and 1.5 million people currently (2012) suffer from Parkinson disease in the U.S. The large pool of patients that suffer from depression, stroke, anxiety disorders, lower back pain, urinary incontinence, and tremor offers the neuromodulation industry opportunities to grow in the next five years. The market for treatment of tinnitus, in particular, represents an emerging application of neuromodulation. According to the American Tinnitus Association, about 50 million people currently (2012) suffer from this disease in the U.S.

This report estimates the market for six major segments, namely, spinal cord stimulation, deep brain stimulation, sacral nerve stimulation, vagus nerve stimulation, gastric electrical stimulation, transcranial magnetic stimulation, and others. The report also estimates the market for different neuromodulation techniques as well as geographic analysis of each segment in North America, Europe, Asia-Pacific, and Rest of the World. As technologies develop and the number of trained physician increases, the likelihood of neuromodulation being seen as life-changing treatment will increase dramatically. It is estimated that the market for neuromodulation will be shared largely by deep brain stimulation and spinal cord stimulation.

The key players in the neuromodulation devices market are Medtronic, Inc. (U.S.), Cyberonics, Inc. (U.S.), Boston Scientific Corporation (U.S.), St. Jude Medical (U.S.), Enteromedics, Inc (U.S.), Neuropace, Inc (U.S.), Zynex, Inc (U.S.) and Neuronetics, Inc (U.S.). The emerging players in this market are Functional Neuromodulation, Ltd (U.S.), Microtransponder (U.S.), and Neurosigma, Inc (U.S.).

Scope of the Report

The research report categorizes the global neuromodulation devices market by procedure, technology, and application. These markets are broken down into segments and sub-segments, providing exhaustive value-volume analysis for 2010, 2011, and 2012 as well as forecast up to 2017. Each market is also analyzed by geography (North America, Europe, Asia-Pacific, and Rest of the World to provide in-depth information on the global scenario.

Global Neurostimulation Devices Market, by Procedure:

Internal Neurostimulation

Spinal Cord Stimulation (SCS)

  • Failed Back Surgery Syndrome
  • Chronic Pain
  • Ischemic Pain
  • Others
Deep Brain Stimulation (DBS)
  • Movement Disorders
  • Parkinson’s Disease
  • Alzheimer’s Disease
  • Dystonia
  • Tourette’s Syndrome
  • Others
  • Chronic Pain
  • Depression
  • Post-Traumatic Coma
Sacral Nerve Stimulation (SNS)
  • Urine Incontinence
  • Fecal Incontinence
Vagus Nerve Stimulation (VNS)
  • Epilepsy disease
  • Heart Failure
  • Tinnitus
  • Others
Gastric Electrical Stimulation (GES)
  • Gastroparesis
  • Others
External Neurostimulation
  • Transcranial Magnetic Stimulation (TMS)
  • Depression
  • Tinnitus
  • Migraine
  • Stroke
  • Others
  • Transcutaneous Electrical Nerve Stimulation (TENS)
Global Neurostimulation Devices Market, by Geography
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
Contact for further information on this report.

Global Biofertilizers Market by Types, Applications & Geography - Trends & Forecasts to 2017

Biofertilizers are preparations containing living cells or latent cells of efficient strains of micro-organisms which helps the crop plants in uptake of nutrients from the soil. Once applied the biofertilizers quickens the microbial activities in the soil. These microorganisms generate plant nutrients like nitrogen and phosphorous through the activities in the soil or rhizosphere which is ultimately made available to the plants. The demand for biofertilizers is increasing due to the stress on reducing environmental pollution and the motive of reducing the usage of chemical fertilizers.

The global biofertilizers market consists of nitrogen fixing biofertilizers, phosphate solubilizing biofertilizers, potash mobilizing biofertilizers and other biofertilizers like Zinc and Sulphur solubilizing biofertilizers. Nitrogen fixing biofertilizers are the dominant sector of this market in terms of market revenue.

The global biofertilizers market is dominated by Europe and Latin American countries like Argentina, which is a part of ROW together accounting for 80% of the market revenue. Asia-Pacific is estimated to be the fastest growing region in terms of revenue. Growth is particularly high in emerging countries such as China, India due to the rising awareness among the population triggered by government promotion. The rate of production of biofertilizers has also increased due to the favorable policies designed by government in various countries.

The driving factors of the global biofertilizers market are increased demand for organic food products, promotion of biofertilizers by various government agencies to create awareness among the masses and environmental hazards associated with chemical fertilizers. The global biofertilizers market is restrained by many factors such as lack of awareness about the concept of biofertilizers which is restraining the growth of the industry. Various advantages of chemical fertilizers are another factor which is holding back the customers from making a switch to biofertilizers. Low rate of adoption is due to the disadvantages associated with biofertilizers. Leading manufacturers are focused on expansion of the business in the domestic market and setting up new plant for increasing production capacity as well as product line.

We have used various secondary sources such as encyclopedia, directories, and databases to identify and collect information useful for this extensive commercial study of biofertilizers market. The primary sources – experts from related industries and suppliers have been interviewed to obtain and verify critical information as well as to assess the future prospects of biofertilizers.

Report Details:
Published: January 2013
No. of Pages: 202
Price:Single User License:US$4650  Corporate User License:US$7150

To capitalize on the growth trend in the global biofertilizers market, several leading companies are rushing in to the development and manufacturing of effective strains of microorganisms. Growing demand for biofertilizers is forcing the global players to add new varieties to their product offerings. We have also profiled leading players of this industry with their recent developments and other strategic industry activities. These include: CBF China Biofertilizers AG (Germany), Mapleton Agribiotec PTY Ltd. (Australia), Nutramax Laboratories Inc. (U.S.), Novozyme (Denmark), Growing Power Hairy Hill L.P. (Canada) and Rizobacter Argentina S.A. (Argentina).

Scope of the report

This research report categorizes the global market for biofertilizers on the basis of Types, Applications, and geography; forecasting revenue and analyzing trends in each of the submarkets:

On the basis of types:
  • Nitrogen fixing biofertilizers
  • Phosphate solubilizing biofertilizers
  • Potash mobilizing biofertilizers
  • Others

On the basis of Applications:
  • Cereals
  • Pulses and Oilseeds
  • Fruits and Vegetables
  • Plantations
  • Others

On the basis of geography:
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the World
Contact for further information on this report.

Metabolomics Market By Applications and Indication Forecasts from 2012 to 2017

Over the last decade, genomics and proteomics have been used as key tools to discover potential drug targets and to better understand the complexities of biology. To balance research in these areas, metabolomics, a new science is evolving for analyzing the basic metabolic changes taking place in a living organism. Metabolomics is thus an emerging concept which refers to the systematic study of the distinctive chemical fingerprints generated in a particular cellular process.

Metabolomics Market – Analysis of Global Technology, Application Trends and Landscape 2012-2017 report covers the market by disease indications along with the applications and metabolite profiling for biomarker discovery applications. In addition, it also includes the factors driving and restraining the market and covers the market scenario in the U.S., Europe, Asia and the Rest of the World (ROW). This report will provide the company profiles of key companies along with the competitive analysis.

The Global Metabolomics market is showing a double digit growth (CAGR 35%) due to supportive factors such as, (i) increased willingness of biotechnology and pharma companies to adopt metabolomics concept to drive R&D activity within the industry, (ii) rapid growth of metabolomics data analysis softwares and solutions, and (iii) the advancement of analytical technologies. Metabolomics is used in the identification of new biomarkers, which indicate a change in the physiological state of a cell or tissue. Biomarker screening is important in the process of new drug discovery, and is also a key in vitro diagnostics tool. Additionally it is also being used for environmental toxicology screening. While, there are major concerns of this market such as the validation challenges, the positive aspects may very well offset the market restraints to aid the market grow at an exceptional rate.

The report also profiles leading participants of this industry with their recent developments and other strategic industry activities. These include: Metabolon Inc (U.S.), Metanomics (Germany), Metabolomic Technologies Inc. (U.S.), Human Metabolome Technologies (Japan), Beckman Coulter (U.S.), Agilent Technologies Inc (U.S.), Bruker Corporation (U.S.), Waters Corporation (U.S.), Biocrates Lifesciences (Austria), Chenomx Inc (Canada), Eisai co. ltd (Japan), Nextgen Metabolomics (U.S.), Phenomenome Discoveries Inc. (Canada) and Metabolomic Discoveries (Germany).

Report Details:
Published: January 2013
No. of Pages: 136
Price:Single User License:US$4650     Corporate User License:US$7150

Scope of the Report
  • This technology report categorizes the market for metabolomics by geographical region (including the important countries in each region), applications, and indications, forecasting the market value in revenue by analyzing the trends in detection instruments and separation techniques (E.g. HPLC, Capillary Electrophoresis).
  • A detailed description of global technological developments and evolving trends in the field of metabolomics with key prominence on product innovations by industries and collaborative efforts by the academic research institutions.
  • A comprehensive picture of different types of detection instruments available for metabolite analysis (e.g. Mass Spectrometry, NMR, Electrochemical detection and Ion mobility spectrometer), prioritized based on critical criterias through Analytical Hierarchy Process (AHP).
  • An impact analysis of major drivers, restraints and challenges influencing the adoption and growth of metabolomics market during the forecast period from 2012 to 2017.
  • Market size - Global market forecast for the next 5 years from 2012 – 2017 by including demand side analysis and strategic recommendations for technology/product developers.
  • Competitive landscape based on the analysis of key patents and research publications that gives an insight into prominent activities and global participants. 
Contact for further information on this report. 

Jan 13, 2013

China’s Jet Fuel Market Research and Investment Prospect Forecast, 2012-2017

According to the National Bureau of Statistics, China kerosene apparent consumption was 18.382 million tons in 2011, up 5.1% year-on-year. The apparent consumption of December was 1.615 million tons, up 3.9% month-on-month. The domestic aviation fuel production was 18.798 million tons in 2011, increasing 10.1% year-on-year; export volume was 6.566 million tons, up 7.9% year-on-year. The output of refined oil product and kerosene was 2.0129 million tons in Jiangsu Province in 2011, up 21.6% year-on-year. According to the relevant data, jet fuel output of Sinopec accounted for about 73% of the domestic production.

In recent years, the growth of domestic kerosene and jet fuel are relatively stable. 2005-2011, China kerosene production rose from 9,886,000 tons to 18,798,000 tons, having an average annual growth of 10.1%; jet fuel production rose to 18.798 million tons from 8.908 million tons, obtaining an average annual growth of 11.8%. According the above data, the kerosene output in 2012 was 20.678 million tons; jet fuel output was 21.016 million tons. The kerosene output will reach 33.3 million tons in 2017; jet fuel output will be about 36.7 million tons.
Companies mentioned in this Report:
  • PetroChina Co. Ltd.
  • SINOPEC Nanjing Branch
  • SINOPEC Shanghai Petrochemical Co. Ltd
  • China National Aviation Fuel
  • West Pacific Petrochemical Co. Ltd. Dalian 

Report Details:
Published: December 2012
No. of Pages: 70
Price:Single User License:US$2300          Corporate User License:US$3000 

1. China’s Jet Fuel Products Overview
1.1 Products Definition, Property and Application Characteristics
1.1.1 Products Definition and Property
1.1.2 Classification
1.1.3 Application Characteristics
1.2 Development History

2. Foreign Jet Fuel Market Overview
2.1 U.S. Jet Fuel Market Overview  
2.1.1 U.S. Would Like to Directly Transform Seawater into Jet Fuel so as to Break Through the Energy Bottleneck 
2.1.2 U.S. Jet Fuel Export Volume Increases
2.2 Japan’s Jet Fuel Market Overview
2.3 Russia’s Jet Fuel Market Overview

3. China’s Jet Fuel Market Environment Analysis
3.1 Economic Development Environment in China 
3.1.1 Economic Development Status
3.1.2 GDP
3.1.3 Fixed Asset Investment
3.1.4 Import and Export Volume and Growth Rate 
3.1.5 China's Macroeconomic Development Forecast
3.2 Industry Relevant Policy, Regulations and Standards
3.2.1 Industry Relevant Policy and Regulations in China
3.2.2 Industry Relevant Standards at Home and Abroad

4. Status Quo of China’s Jet Fuel Industry
4.1 Market Concentration
4.2 Competition Situation
4.2.1 CNPC Jet Fuel Production Enterprise
4.2.2 Sinopec Jet Fuel Production Enterprise

5. Industry Chain of China’s Jet Fuel Industry
5.1 Development of the Upstream Industry
5.2 Development of the Downstream industry
5.2.1 Asia Has Become the Leader of Surfactant Market 
5.2.2 Fushun Xihua Alkylbenzene Accounts for Half of the Domestic Market
5.2.3 Taiwan Ho Tung Alkylbenzene Production
5.2.4 Alkylbenzene Manufacturers
5.2.5 Jet Fuel Export Company

6. Supply and Demand of China’s Jet Fuel 
6.1 Output
6.2 Output Forecast
6.3 Factors Affecting Supply
6.3.1 International and Domestic Crude Oil, Refined Oil Market 
6.3.2 Policy of the State and Manufacturers
6.3.3 Production Technologies and Technic
6.3.4 Supply, Demand and Price of Related Products 
6.3.5 Railway Transportation
6.4 Output and Market Demand Forecast of China’s Jet Fuel
6.4.1 Demand Characteristics
6.4.2 Demand Regions
6.4.3 Demand Forecast
6.5 Factors Affecting Demand in China
6.5.1 Development of the Domestic Civil Aviation Transport Industry
6.5.2 Domestic and Foreign Political and Military Conflicts
6.5.3 Development of the Defense Industry
6.6 Price Trend of China’s Jet Fuel 
6.6.1 Market Environment
6.6.2 Market Price
6.6.3 Price Forecast 2009-2012

7. Import and Export of China’s Jet Fuel
7.1 Import and Export Volume and Amount
7.2 Source of Import Sorted by Trade Volume
7.3 Export Destinations Sorted by Trade Volume

8. Domestic Key Jet Fuel Manufacturers
8.1 PetroChina Co. Ltd.
8.1.1 Company Profile
8.1.2 Products Profile
8.1.3 Oil Refining and Chemical Production
8.1.4 Marketing Situation
8.1.5 Business Performance
8.2.1 Company Profile
8.2.2 Refining Production 
8.2.3 Business Performance
8.3 SINOPEC Nanjing Branch
8.3.1 Company Profile
8.3.2 Business Introduction
8.3.3 Business Performance
8.4 SINOPEC Shanghai Petrochemical Co. Ltd.
8.4.1 Company Profile
8.4.2 Products Profile
8.4.3 Production Capacity
8.5 China National Aviation Fuel
8.5.1 Company Profile
8.5.2 Products Profile
8.5.3 Business Performance
8.6 West Pacific Petrochemical Co. Ltd. Dalian 
8.6.1 Company Profile 
8.6.2 Development History 

9. Production Technique of Jet Fuel
9.1 Crude Oil Unit 
9.2 Hydrocracking and Hydrotreating Apparatus
9.3 Kerosene Hydrotreating Unit 

10. Investment Risks and Opportunity of Jet Fuel Industry
10.1 Investment Risks
10.1.1 Upstream Industry Risk
10.1.2 Downstream Industry Risk 
10.2 Investment Opportunity 
10.2.1 Development Status Quo of Refining Industry
10.2.2 Investment Opportunity